Product Details



PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET - 2024

 Pharmaceutical Contract Development and Manufacturing Market by Service (Pharmaceutical, Biologics, Active Pharma Ingredients, Tablet, Capsule, Parenteral, Oral Liquid), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) & Region Market - Global Forecast to 2024



The Pharmaceutical Contract Development and Manufacturing market, in terms of value, is projected to grow at a CAGR of XX% from 2019 to 2024. The market is estimated to be USD XX Billion in 2019, and is projected to reach XX Billion by 2024. In this study, 2018 has been considered the base year, and 2019 to 2024 the forecast period, for estimating the market size of the global market.

OBJECTIVES OF THE STUDY

  • To define, describe, and forecast the Pharmaceutical Contract Development and Manufacturing market segmented by Service (Pharmaceutical, Biologics, Active Pharma Ingredients, Tablet, Capsule, Parenteral, Oral Liquid), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) & Region
  • To forecast the market size in terms of value for various segments with respect to four main regions: North America, Europe, APAC, Latin America and Middle East & Africa
  • To provide detailed information regarding the major factors influencing the growth of the Pharmaceutical Contract Development and Manufacturing market (drivers, restraints, opportunities, and industry-specific challenges)
  • To provide a detailed overview of the value chain in the Pharmaceutical Contract Development and Manufacturing market and analyze the market trends with Porter’s five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Pharmaceutical Contract Development and Manufacturing market
  • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Pharmaceutical Contract Development and Manufacturing market

Scope of the Report:

This research report categorizes the Pharmaceutical Contract Development and Manufacturing market into the following segments and sub segments:

Pharmaceutical Contract Development and Manufacturing Market, by Service

    Pharmaceutical Manufacturing Services

        Pharmaceutical API Manufacturing

        Pharmaceutical FDF Manufacturing

            Parenteral/Injectable

            Tablet

            Capsule

            Oral Liquid

            Other Formulations

    Biologics Manufacturing Services

        Biologics API Manufacturing

        Biologics FDF Manufacturing

    Drug Development Services

Pharmaceutical Contract Development and Manufacturing Market, by End User

Big Pharma

Small & Mid-size Pharma

Generic Pharmaceutical Companies

Other End Users

Pharmaceutical Contract Development and Manufacturing market By Region:

North America

South America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1 Introduction

2 Research Methodologies

3 Executive Summaries 

4 Premium Insights
    4.1 Pharmaceutical Contract Development and Manufacturing: Market Overview
    4.2 Pharmaceutical Contract Development and Manufacturing Market: By Service
    4.3 Pharmaceutical Contract Development and Manufacturing Market: By End User
    4.4 Pharmaceutical Contract Development and Manufacturing Market: Geographic Growth Opportunities

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Opportunities
           5.2.3 Challenges
           5.2.4 Trends

6 Pharmaceutical Contract Development and Manufacturing Market, By Service
    6.1 Introduction
    6.2 Pharmaceutical Manufacturing Services
           6.2.1 Pharmaceutical API Manufacturing Services
           6.2.2 Pharmaceutical FDF Manufacturing Services
                    6.2.2.1 Parenteral/Injectable Manufacturing Services
                    6.2.2.2 Tablet Manufacturing Services
                    6.2.2.3 Capsule Manufacturing Services
                    6.2.2.4 Oral Liquid Manufacturing Services
                    6.2.2.5 Other Formulations
    6.3 Drug Development Services
    6.4 Biologics Manufacturing Services
           6.4.1 Biologics API Manufacturing Services
           6.4.2 Biologics FDF Manufacturing Services

7 Pharmaceutical Contract Development and Manufacturing Market, By End User
    7.1 Introduction
    7.2 Big Pharma
    7.3 Small & Mid-Size Pharma
    7.4 Generic Pharmaceutical Companies
    7.5 Other End Users

8 Pharmaceutical Contract Development and Manufacturing Market, By Region
    8.1 Introduction
    8.2 Europe
    8.3 North America
    8.4 Asia Pacific
    8.5 Latin America

    8.6 Middle East & Africa

9 Competitive Landscape

10 Company Profiles
     (Business Overview, Products & Services, Financials, Recent Developments)* 
     10.1 Thermo Fisher Scientific Inc.
     10.2 Catalent, Inc.
     10.3 Lonza Group Ltd
     10.4 Recipharm AB
     10.5 Vetter Pharma International GmbH
     10.6 Famar Health Care Services
     10.7 Abbvie Inc.
     10.8 Aenova Group
     10.9 Consort Medical Plc
     10.10 Almac Group
     10.11 Siegfried Holding AG
     10.12 Evonik Industries AG
     10.13 Boehringer Ingelheim International GmbH

*Details Might Not Be Captured in Case of Unlisted Companies.

Single User   1530.00

Multiple User   2200.00
Latest Product